Pulmonology · Medical Literature
The Effect of Transpulmonary Pressure-Guided Positive End-Expiratory Pressure Titration on Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome Patients: A Single-Center, Randomized Controlled Pilot Pathophysiological Study.
Abstract
To compare the function of positive end-expiratory pressure (PEEP) titration guided by transpulmonary pressure (Ptp) with traditional lung-protective ventilation to optimize pulmonary arterial compliance (Cpa) in acute respiratory distress syndrome (ARDS) patients. A single center, randomized controlled pilot pathophysiological study. A respiratory ICU in China. Adult patients diagnosed with ARDS who had received invasive mechanical ventilation for less than 72 hours. Patients were randomized to the Ptp group or empirical low tidal volume lung-protective group. The primary endpoint was the difference in the Cpa dynamic changes between the two groups during the first 72 hours of intervention following enrollment. A total of 40 patients were included in the study, with 20 patients in the Ptp group and 20 patients in the control group. The Cpa in the Ptp group was 3.98 ± 0.46 mL/mm Hg at randomization, which was not significantly different from that in the control group (3.89 ± 0.40 mL/mm Hg). The Cpa in the Ptp group was significantly higher than that in the control group (p = 0.039) during the 72 hours of dynamic monitoring performed after enrollment. However, Cpa did not change significantly over time, and there was no significant difference in the trend between the two groups. There was a significant difference in the dynamic change of the right ventricular ejection fraction and oxygen delivery index between the two groups within 72 hours after randomization (p < 0.05). The change in the right ventricular end-diastolic transverse diameter/left ventricular end-diastolic transverse diameter ratio and in the tricuspid annular plane systolic excursion was significantly different between the two groups (p < 0.05). Ptp-guided PEEP titration was superior to traditional lung-protective ventilation in maintaining a higher Cpa and preserving right ventricular function in patients with moderate-to-severe ARDS caused by pneumonia.
Clinical relevance
In mechanically ventilated adult ARDS patients, does PEEP titration guided by transpulmonary pressure (Ptp) improve pulmonary arterial compliance (Cpa) over 72 hours compared with empirical low tidal volume lung-protective ventilation? __SNAPSHOT__ {"studyDesign":"Single-center, randomized controlled pilot pathophysiological study","setting":"Respiratory ICU, single center, China","sampleSize":"n=40 (Ptp group: n=20; control group: n=20)","population":"Adult patients diagnosed with ARDS who had received invasive mechanical ventilation for less than 72 hours prior to enrollment","intervention":"PEEP titration guided by transpulmonary pressure (Ptp), measured via esophageal manometry (method of Ptp measurement not further detailed in the abstract)","comparator":"Empirical low tidal volume lung-protective ventilation (standard ARDSNet-style strategy)","primaryOutcome":"Difference in dynamic changes in pulmonary arterial compliance (Cpa, mL/mm Hg) between the two groups over the first 72 hours of intervention following enrollment","followUp":"72 hours (primary monitoring window); longer-term clinical outcomes not reported in the abstract","fundingSource":"Not reported"}
Key findings
At randomization, baseline Cpa was similar between groups (Ptp group: 3.98 ± 0.46 mL/mm Hg; control group: 3.89 ± 0.40 mL/mm Hg; between-group difference not statistically significant, p-value not reported for baseline comparison). Over the 72-hour dynamic monitoring period, Cpa in the Ptp group was statistically significantly higher than in the control group (p = 0.039). Absolute effect size (mean difference in Cpa at each time point or at 72 hours), relative effect size, confidence intervals, and NNT/NNH are not reported in the abstract. Secondary outcomes (e.g., oxygenation indices, driving pressure, ventilator-free days, ICU length of stay, mortality, right ventricular function, adverse events) are not described in the available abstract. No clinically important adverse events are reported in the abstract.
Practice implications
This pilot RCT provides preliminary pathophysiological evidence that Ptp-guided PEEP titration sustains a higher pulmonary arterial compliance over 72 hours compared with empirical lung-protective ventilation in mechanically ventilated ARDS patients at a single Chinese respiratory ICU. Because Cpa is a physiological surrogate — not a validated patient-centered endpoint — the clinical importance of this statistically significant difference (p = 0.039) cannot be determined from the abstract alone. Improved Cpa may reflect reduced right ventricular afterload and pulmonary vascular stress, but whether this translates into meaningful improvements in RV function, mortality, ventilator-free days, or other outcomes is not established by this study. The finding applies to adults with ARDS receiving invasive mechanical ventilation for less than 72 hours in a single Chinese respiratory ICU setting; generalizability to other ARDS etiologies, patient populations (e.g., obese, post-surgical, immunocompromised), or healthcare systems is unknown. The study was explicitly designed as a pilot pathophysiological study and is not powered or intended to support practice change. IMPORTANT LIMITATION OF THIS SUMMARY: Only the abstract was available for analysis; full methodology, complete results tables, subgroup analyses, secondary outcomes, and adverse event data could not be reviewed. __LIMITATIONS__ Very small sample size (n=40 total; n=20 per arm), consistent with a pilot study; severely underpowered for any patient-centered endpoint,Single-center design at one Chinese respiratory ICU substantially limits generalizability,Primary endpoint (Cpa) is a physiological surrogate; no patient-centered outcomes (mortality, ventilator-free days, ICU LOS) reported in the abstract,Short follow-up window of 72 hours; no data on longer-term clinical outcomes,Method of Ptp measurement (e.g., esophageal balloon placement, calibration protocol) and specific PEEP titration algorithm not described in the abstract, precluding reproducibility assessment,Blinding status of clinicians and outcome assessors not reported in the abstract,The statistical significance threshold (p = 0.039) is marginal, and with multiple potential time-point comparisons over 72 hours, risk of type I error cannot be excluded without full statistical analysis plan review,Absolute effect sizes, confidence intervals, and NNT/NNH not reported, making clinical magnitude of difference uninterpretable,Funding source not reported; potential conflicts of interest cannot be assessed,Pilot study by design — not intended as definitive evidence; authors' own framing as 'pathophysiological' study confirms hypothesis-generating rather than practice-informing intent __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ This small (n=40) single-center pilot RCT found that Ptp-guided PEEP titration produced statistically higher pulmonary arterial compliance over 72 hours compared with empirical lung-protective ventilation in ARDS (p=0.039), but the clinical magnitude, durability, and patient-centered implications of this difference are not established. As an explicitly labeled pilot pathophysiological study powered only for a surrogate endpoint, these findings should be considered hypothesis-generating and do not support a change in current PEEP titration practice. Adequately powered multicenter RCTs examining patient-centered outcomes (mortality, ventilator-free days, RV function) are needed before this approach can be recommended for routine adoption.